IP is just as much about collaboration as exclusivity for oncology tech companies
IP advocacy group Ideas Matter showcased the pivotal role of IP in the development of cancer treatments at an event in London today. Representatives from a number of companies active in the field of cancer diagnostics attempted to counter the…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.